Tue 14'th Aug 2018
Endocyte Stock Analysis
Technical stock analysis for Tue 14'th Aug 2018
|Shorts||7.44% ( 2018-07-31 )|
Endocyte gained 3.48% in the last trading day, rising from $15.80 to $16.35 The price has risen in 6 of the last 10 days and is up by 6.72% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 236 367 more shares were traded than the day before. In total, 746 354 shares bought and sold for approximately $12.20 million.
Endocyte lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 23.07% during the next 3 months and, with 90% probability hold a price between $18.71 and $22.91 at the end of this period.
Only positive signals in the chart today. Endocyte holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $16.05 and $15.82. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday August 13, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSI14 is 62 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $14.45 and $13.79.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Endocyte finds support just below today's level at $14.45. If this is broken, then the next support from accumulated volume will be at $13.79 and $13.51.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.89 between high and low, or 5.68%. For the last week, the stock has had a daily average volatility of 4.04%.
Our recommended stoploss: $15.55 (-4.92%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
Very Low Low Medium High Very High
Endocyte holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Strong Buy Candidate.Click for Top 5 Strong Buy Candidates
|ECYT $16.35 $0.55(3.48%)|
ECYT is up $0.55 today, but where's it headed in September?
|Zacks Investment Research is releasing its prediction for ECYT based on the 1-3 month system that more than doubles the S&P 500.
Click here – the ECYT analysis is free »